Phoenix's EmeraNova launches Catalyst accelerator with up to $200K per startup
What's the deal? Phoenix medtech company EmeraNova has launched Catalyst, a four-month accelerator for startups in tissue restoration and advanced wound care. The program offers validation, mentorship, and potential investment of up to $200,000 per venture. Applications are open now.
Who's it for? EmeraNova is targeting medtech, biotech, and pharma companies that have demonstrated proof of concept and reached later development stages. The program runs through four phases: diagnostic and discovery; a product and commercialization roadmap; investor readiness; and a Demo Day pitch to EmeraNova leadership, partners, and investors.
Why now? Catalyst is EmeraNova's first major move since BioLab HoldingsDealroom has a profile for this one. Try Dealroom → launched the EmeraNova identity in October 2026 to build a broader tissue-restoration platform. The company has since followed with a wound-imaging collaboration with Kent Imaging.
What's the endgame? EmeraNova says too many healthcare breakthroughs never reach patients, and Catalyst aims to close that gap. "Our passion lies in identifying new technologies, and through Catalyst we can ensure the best solutions in tissue restoration are adopted into our toolbox and make it into providers' hands," said Dr. Carlos Encinas, chief science officer.
President and chief executive officer Jaime Leija framed the program as mentorship paid forward. "Catalyst gives us a very unique opportunity to aid startup companies in the very early stages of product development and to loan them our knowledge, expertise and resources," he said.
The signal: Catalyst lands in a tissue-restoration market where commercial reach is increasingly decisive — recent deals saw AROA Biosurgery team with MölnlyckeDealroom has a profile for this one. Try Dealroom → to widen US access, while MIMEDXDealroom has a profile for this one. Try Dealroom → moved to acquire Sanara MedTechDealroom has a profile for this one. Try Dealroom →. Phoenix already hosts health-innovation programs such as the Mayo Clinic–ASU Health Care Accelerator and LaunchAZ, but Catalyst's narrower focus on later-stage tissue-restoration ventures — pairing funding potential with commercialization, regulatory, and investor-readiness support — sets it apart.
Read more: inbusinessphx.com
Image credit: Generated with Gemini
